專業人才

王宏銘, M.D.
單位: 林口長庚醫院/長庚大學
現職:
  • 林口長庚醫院教授級主治醫師
  • 長庚大學副教授
聯絡地址: 桃園縣龜山鄉復興街五號
電話: 03-328-1200 傳真: 03-3281200-2362
E-mail: whm526@cgmh.org.tw

研究領域:
  • 腫瘤
  • 癌症

工作經歷:
  1. 1985/07~1986/06 長庚醫院實習醫師
  2. 1986/08~1987/07 台北醫學院附設醫院內科部住院醫師
  3. 1987/08~1990/07 長庚醫院內科部住院醫師
  4. 1990/08~1992/07 長庚醫院血液腫瘤科臨床研究員
  5. 1992/08～迄今 長庚醫院血液腫瘤科主治醫師
  6. 2001/02~2008/08 長庚大學臨床助理教授(兼任)
  7. 2002/03~2005/04 長庚技術學院臨床助理教授(專任)
  8. 2005/05~2007/12 長庚技術學院臨床副教授(專任)
  9. 2006/07~2011/01 長庚醫院血液腫瘤科科主任
  10. 2008/08～迄今 長庚大學臨床副教授(專任)
  11. 2011/10~2017/06 林口長庚醫院內科部副部長


學歷:
台北醫學大學醫學系

代表論文:

  1. Liao CT, Wang HM(co 1st), Chang JT, Lin CY, Ng SH, Huang SF, et al. Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2010;77(2):421-9.
  2. Chan SC, Wang HM(co-1st), Yen TC, Lin CY, Chin SC, Liao CT, et al. (1)(8)F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study. Eur J Nucl Med Mol Imaging 2011;38(9):1607-19.
  3. Hsieh CH, Chang JW, Hsieh JJ, Hsu T, Huang SF, Liao CT, Wang HM (corresponding). Epidermal growth factor receptor mutations in patients with oral cavity cancer in a betel nut chewing-prevalent area. Head Neck 2011;33(12):1758-64.
  4. Chan SC, Wang HM(co-1st), Ng SH, Hsu CL, Lin YJ, Lin CY, et al. Utility of 18F-fluoride PET/CT and 18F-FDG PET/CT in the detection of bony metastases in heightened-risk head and neck cancer patients. J Nucl Med 2012;53(11):1730-5.
  5. Hsu CL. Chang KP. Lin CY. Chang HK. Wang CH. Lin TL. Liao CT. Tsang NM. Lee LY. Chan SC. Ng SH. Li HP. Chang YS. Wang HM(corresponding). Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma. Head Neck 2012;34(8):1064-70.
  6. Tsan DL, Lin CY, Kang CJ, Huang SF, Fan KH, Liao CT, Chen IH. Lee LY. Wang HM(corresponding). Chang JT.. The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity. Radiat Oncol 2012;7:215.
  7. Wang HM(corresponding). Impact of palliative care consultative service on disease awareness for patients with terminal cancer. Support Care Cancer 2013;21(7):1973-81.
  8. Hsieh CH, Hsu CL, Wang CH, Liaw CC, Chen JS, Chang HK, Yang TS, Chang JW, Lin YC, Liau CT, Tsang NM, Chang JT, Ng SH, Wang, HM(corresponding). Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma. Biomed J 2013;36(5):229-36.
  9. Hsu CL, Chan SC, Chang KP, Lin TL, Lin CY, Hsieh CH, Huang SF, Tsang NM, Lee LY, Ng SH, Wang HM(corresponding). Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma. Oral Oncol 2013;49(6):620-5.
  10. Wang HM, Hsu CL, Heish CH, Fan KH, Lin C.Y, Chang JTC, Huang SF, Chen IH, Liao CT, Ng SK. Concurrent Chemoradiotherapy Using Cisplatin, Tegafur and Leucovorin for Advanced Squamous Cell Carcinoma of the Hypopharynx and Oropharynx. Biomed J 2014 (ahead of print).


所有論文著作一覽表

學會與認證:

  • 台灣內科醫學專科醫師及會員
  • 中華民國癌症醫學會腫瘤內科專科醫師及會員

殊榮:
  1. The 7th Taiwan Joint Cancer Conference, 2002 優秀壁報論文獎
  2. The 11th Taiwan Joint Cancer Conference, 2006 優秀壁報論文獎
  3. 98年度長庚醫誌優良審查委員